Literature DB >> 21865711

Influence of Waldeyer's ring hypertrophy on snoring and sleep apnea.

Desiderio Passàli1, Michele De Benedetto, Maria Lauriello, Francesco Maria Passàli.   

Abstract

Severe adenotonsillar hypertrophy can be the main cause of nocturnal respiratory affections, as confirmed by the improvement of symptoms seen after adenotonsillectomy. Unsuccessful surgical treatment can be due to craniofacial morphological alterations. Hypotony of the pharyngeal muscles could also be responsible together with tonsil hypertrophy. In our study, we enrolled 125 patients (87 males and 38 females), aged from 3 to 8 years, suffering from chronic snoring. All the patients underwent adenotonsillectomy. The follow-up was carried out at 2, 4 and 6 months after the operation. Snoring and nocturnal apneas were no longer present in almost all the patients. Overnight polysomnography remains the gold standard diagnostic test for obstructive sleep apnea syndrome, but its feasibility in clinical practice is debated. Rhinomanometry, which gives an objective evaluation of ventilatory nasal function, acoustic rhinometry, which measures the cross-section in fixed nasal areas, and nasal mucociliary transport time can be considered useful tests to evaluate the cause of respiratory obstruction.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21865711     DOI: 10.1159/000324660

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  2 in total

1.  Update of endoscopic classification system of adenoid hypertrophy based on clinical experience on 7621 children.

Authors:  Michele Cassano; Eugenio De Corso; Valeria Fiore; Rossana Giancaspro; Antonio Moffa; Manuele Casale; Eleonora Maria Consiglia Trecca; Dario Antonio Mele; Pasquale Cassano; Matteo Gelardi
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04-08       Impact factor: 2.618

2.  Partial resection of hypertrophic torus tubarius for recurred snoring: Case series.

Authors:  Jeong-Whun Kim; Chae Seo Rhee; Hahn Jin Jung
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.